John G Ullman & Associates Inc. trimmed its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 29.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 407,708 shares of the biopharmaceutical company’s stock after selling 169,128 shares during the quarter. Pfizer […] Read this story
